Arcturus Therapeutics Holdings Inc logo

Arcturus Therapeutics Holdings Inc

NAS:ARCT (USA)  
2
1
$ 26.25 -0.99 (-3.63%) 04:00 PM EST
P/E:
8.78
P/B:
2.45
Market Cap:
$ 698.21M
Enterprise V:
$ 433.28M
Volume:
333.85K
Avg Vol (2M):
438.50K
Volume:
333.85K
Market Cap $:
698.21M
PE Ratio:
8.78
Avg Vol (2M):
438.50K
Enterprise Value $:
433.28M
PB Ratio:
2.45

Business Description

Arcturus Therapeutics Holdings Inc logo
Arcturus Therapeutics Holdings Inc
NAICS : 325414 SIC : 2834
ISIN : IL0011280240
Description
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the segment of research and development of medical applications for nucleic acid-focused technology. The product pipeline of the company includes LUNAR-OTC, LUNAR-CF, and LUNAR-COV19.
Name Current Vs Industry Vs History
Cash-To-Debt 10.05
Equity-to-Asset 0.66
Debt-to-Equity 0.11
Debt-to-EBITDA 0.37
Interest Coverage 19.16
Piotroski F-Score 7/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 3.96
Distress
Grey
Safe
Beneish M-Score 0.89
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 35.47
9-Day RSI 35.86
14-Day RSI 39.17
6-1 Month Momentum % 121.54
12-1 Month Momentum % 132.6

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.26
Quick Ratio 4.26
Cash Ratio 3.58
Days Sales Outstanding 28.44

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -20.6
Shareholder Yield % 1.61

Financials (Next Earnings Date:2023-11-09 Est.)

ARCT's 30-Y Financials
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ARCT

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

Arcturus Therapeutics Holdings Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 262.712
EPS (TTM) ($) 2.99
Beta 2.08
Volatility % 65.23
14-Day RSI 39.17
14-Day ATR ($) 1.600251
20-Day SMA ($) 29.9465
12-1 Month Momentum % 132.6
52-Week Range ($) 13.02 - 37.75
Shares Outstanding (Mil) 26.6

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 7
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Arcturus Therapeutics Holdings Inc Filings

Filing Date Document Date Form
No Filing Data

Arcturus Therapeutics Holdings Inc Stock Events

Event Date Price($)
No Event Data

Arcturus Therapeutics Holdings Inc Frequently Asked Questions

What is Arcturus Therapeutics Holdings Inc(ARCT)'s stock price today?
The current price of ARCT is $26.25. The 52 week high of ARCT is $37.75 and 52 week low is $13.02.
When is next earnings date of Arcturus Therapeutics Holdings Inc(ARCT)?
The next earnings date of Arcturus Therapeutics Holdings Inc(ARCT) is 2023-11-09 Est..
Does Arcturus Therapeutics Holdings Inc(ARCT) pay dividends? If so, how much?
Arcturus Therapeutics Holdings Inc(ARCT) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1